Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail. Elan said on Saturday that that the results of clinical trails of Antegren were promising and "suggest that the agent mechanism of action has potential as a new approach to treating MS".
Elan trials favourable
Elan, the Dublin-based but US quoted drugs company has announced "promising" results from a Multiple Sclerosis drugs trail
From maternity leave to remote working: Submit your work-related questions here
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Sign up to the Business Today newsletter for the latest new and commentary in your inbox









